Melatonin and a 21-aminosteroid attenuate shock after hemorrhage but differentially affect serum cytokines

Journal of Surgical Research

Volumn 64, Issue 1, 1996, Pages 13-18

  Sullivan, Dennis J ^a   Shelby, Jane ^a   Shao, Yuanlin ^a   Affleck, David G ^a   Hinson, Douglas M ^a   Barton, Richard G ^a  

^a UNIVERSITY OF UTAH SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

21 AMINOSTEROID; 21 [4 [2,6 BIS(1 PYRROLIDINYL) 4 PYRIMIDINYL] 1 PIPERAZINYL]PREGNA 1,4,9(11) TRIENE 3,20 DIONE; CYTOKINE; INTERLEUKIN 6; LAZAROID; MELATONIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DRUG EFFECT; HEMORRHAGIC SHOCK; INFLAMMATION; INTRAARTERIAL DRUG ADMINISTRATION; LIPID PEROXIDATION; MALE; MEAN ARTERIAL PRESSURE; MEMBRANE PERMEABILITY; MEMBRANE STABILIZATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; RESUSCITATION; SPLEEN CELL; TISSUE INJURY;

EID: 0030586079     PISSN: 00224804     EISSN: None     Source Type: Journal    
DOI: 10.1006/jsre.1996.0299     Document Type: Article

References (34)

1. 1. Cruickshank, A. M., Fraser, W. D., Burns, H. J. G., et al. Response of serum interleukin-6 in patients undergoing elective surgery of varying severity. Clin. Sci. 79: 161, 1990.
2. 2. Roumen, R. M. H., Hendriks, T., Van Der Ven-Jongekrijg, J., et al. Cytokine patterns in patients after major vascular surgery, hemorrhagic shock, and severe blunt trauma. Ann. Surg. 218: 769, 1993.
3. 3. Ertel, W., Faist, E., Nestle, C., et al. Kinetics of interleukin-2 and interleukin-6 synthesis following major mechanical trauma. J. Surg. Res. 48: 622, 1990.
4. 4. Schluter, B., Konig, B., Bergmann, U., et al. Interleukin-6 a potential mediator of lethal sepsis after major thermal trauma: Evidence for increased IL-6 production by peripheral blood mononuclear cells. J. Trauma 31: 1663, 1991.
5. 5. Bitterman, H., Kinarty, A., Lazarovich, H., et al. Acute release of cytokines is proportional to tissue injury induced by surgical trauma and shock in rats. J. Clin. Immunol. 11: 184, 1991.
6. 6. Ayala, A., Wang, P., Ba, Z. F., et al. Differential alterations in plasma IL-6 and TNF levels after trauma and hemorrhage. Am. J. Physiol. 260: R167, 1991.
7. 7. Roumen, R. M. H., Van Meurs, P. A., Kuypers, H. H. C., et al. Serum interleukin-6 and reactive protein responses in patients after laparoscopic or conventional cholecystectomy. Eur. J. Surg. 158: 541, 1992.
8. 8. Baigrie, R. J., Lamont, P. M., Kwiatkowski, D., et al. Systemic cytokine response after major surgery. Br. J. Surg. 79: 757, 1992.
9. 9. Hall, E. D. Beneficial effects of the 21-aminosteroid U74006-F in acute CNS trauma and hypovolemic shock. Acta Anaesthesiol. Belg. 38: 421, 1987.
10. 10. McCall, J. M., Braughler, J. M., and Hall, E. D. A new class of compounds for stroke and trauma: Effects of 21-aminosteroids on lipid peroxidation. Acta Anaesthesiol. Belg. 38: 417, 1987.
11. 11. Hall, E. D., Yonkers, P. A., and McCall, J. M. Attenuation of hemorrhagic shock by the non-glucocorticoid 21-aminosteroid U74006-F. Eur. J. Pharmacol. 147: 299, 1988.
12. 12. Kalsi, J. K., Clay, D. R., and Hall, N. D. Suppressive effects of a novel antioxidant compound on human T-cell functions in vitro. Agents Actions, Special Conference Issue, C110, 1993.
13. 13. Eversole, R. R., Smith, S. L., Beuving, L. J., and Hall, E. D. Protective effect of the 21-aminosteroid lipid peroxidation inhibitor tirilazad mesylate (U74006-F) on hepatic endothelium in experimental hemorrhagic shock. Circ. Shock 40: 125, 1993.
14. 14. Aoki, N., and Lefer, A. M. Protective effects of a novel nonglucocorticoid, 21-aminosteroid (U74006-F) during traumatic shock in rats. J. Cardiovasc. Pharmacol. 15(2): 205, 1990.
15. 15. Semrad, S. D., Rose, M. L., and Adams, J. L. Effect of tirilazad mesylate (U74006F) on eicosanoid and tumor necrosis factor generation in healthy and endotoxemic calves. Circ. Shock 40: 235, 1993.
16. 16. Stone, W. C., Bjorling, D. E., Southard, J. H., Galbreath, E. J., and Lindsay, W. A. Evaluation of intestinal villus height in rats after ischemia and reperfusion by administration of superoxide dismutase, polyethylene glycol-conjugated superoxide dismutase and two 21-aminosteroids. Am. J. Vet. Res. 53(11): 2153, 1992.
17. 17. Johnson, G., and Lefer, A. M. Protective effects of a novel 21-aminosteroid during splanchnic artery occlusion shock. Circ. Shock 30: 155, 1990.
18. 18. Reiter, R. J. Interactions of the pineal hormone melatonin with oxygen-centered free radicals: A brief review. Braz. J. Med. Biol. Res. 26: 1141, 1993.
19. 19. Pierrefiche, G., Topall, G., Courboin, G., Henriet, I., and Laborit, H. Antioxidant activity of melatonin in mice. Res. Commun. Chem. Pathol. Pharmacol. 80(2): 211, 1993.
20. 20. Pieri, C., Marra, M., Moroni, F., Recchioni, R., and Marcheselli, F. Melatonin: A peroxyl radical scavenger more effective than vitamin E. Life Sci. 55(15): 271, 1994.
21. +2-stimulated ATPase activity induced by alloxan. Am. J. Physiol. 267: E57, 1994.
22. 22. Stephan, R. N., Kupper, T. S., Getta, A. S., Baue, A. E., and Chaudry, I. H. Hemmorhage without tissue trauma produces immunosuppression and enhances susceptibility to sepsis. Arch. Surg. 122: 62, 1987.
23. 23. Hall, E. D., Braughler, J., and McCall, J. M. Role of oxygen radicals in stroke: Effects of the 21-aminosteroids (lazaroids). A novel class of antioxidants. In Current and Future Trends in Anticonvulsant, Anxiety, and Stroke Therapy. New York: Wiley-Liss, 1990. Pp. 351-362.
24. 24. Reiter, R. J. Pineal melatonin: Cell biology of its synthesis and of its physiological interactions. Endocr. Rev. 12: 151, 1991.
25. 25. Reiter, R. J. Melatonin: The chemical expression of darkness. Mol. Cell. Endocrinol. 79: C153, 1991.
26. 26. Shelby, J., Ku, W. W., and Nielson, H. C. Neurohormone and neuropeptide regulation of the post traumatic immune response. In E. Faist (Ed.), Host Defense Alterations of Trauma, Shock and Sepsis-Multiorgan Failure/Immunotherapy of Sepsis. Berlin:Pabst, 1996. In press.
27. 27. Barton, R. G., Sullivan, D. J., Edelman, L., Franklin, R. A., Araneo, B. A., and Shelby, J. The effect of dehydroepiandrosterone (DHEA) in modulation of liver glutathione levels and interleukin-6 production after hemorrhagic shock. Submitted for publication, 1995.
28. 28. Wichmann, M. W., Zellweger, R., DeMaso, C. M., Ayala, A., Chaudry, I. H. Melatonin administration attenuates depressed immune functions after trauma-hemorrhage. J. Surg. Res. 63: 256, 1996.
29. 29. Castell, J. V., Andus, T., Kunz, D., Heinrich, P. C. Interleukin-6: The major regulator of acute-phase protein synthesis in man and rat. Ann. NY Acad. Sci. 557: 87, 1989.
30. 30. Gauldie, J., Richards, C., Harnish, D., et al. Interferon β2/B-cell stimulatory factor type 2 shares identity with monocyte-derived hepatocyte-stimulating factor and regulates the major acute phase protein response in liver cells. Proc. Natl. Acad. Sci. USA 84: 7251, 1987.
31. 31. Morrone, G., Liliberto, G., Oliviero, S., et al. Recombinant interleukin-6 regulates the transcription activation of a set of human acute phase genes. J. Biol. Chem. 263: 12554, 1988.
32. 32. Castell, J. V., Gomex-Lechon, M. J., David, M., et al. Recombinant human interleukin-6 (IL-6/BSF-2/HSF) regulates the synthesis of acute phase proteins in human hepatocytes. FEBS Lett. 232: 347, 1988.
33. 33. Ertel, W., Morrison, M. H., Ayala, A., Dean, R. E., and Chaudry, I. H. Interferon-γ attenuates hemorrhage induced suppression of macrophage and splenocyte functions and decreases susceptibility to sepsis. Surgery 111: 177, 1992.
34. 34. Faist, E., Licht, K., Schinkel, C., Zimmer, S., Kim, C., Jochum, M., Frauenberger, P., Zedler, S., and Schildberg, F. W. Gamma interferon (γ-IFN) driven monocytic cytokine release patterns are highly differentiated and depend on inflammation induced states of cellular preactivation. Submitted for publication, 1995.